OTC - ACTIVE INGREDIENT SECTION
ACTIVE INGREDIENTS: OCTINOXATE 2.20% [] TITANIUM DIOXIDE 1.40%
ACTIVE INGREDIENTS: OCTINOXATE 2.20% [] TITANIUM DIOXIDE 1.40%
INACTIVE INGREDIENTS: WATER\AQUA\EAU [] CYCLOPENTASILOXANE [] PHENYL TRIMETHICONE [] BUTYLENE GLYCOL [] DIMETHICONE [] ISOCETYL ALCOHOL [] CAPRYLIC/CAPRIC TRIGLYCERIDE [] ISOHEXADECANE [] WHEAT GERM GLYCERIDES [] PEG/PPG-20/20 DIMETHICONE [] SORBITAN SESQUIOLEATE [] MAGNESIUM SULFATE [] TRIBEHENIN [] HYDROLYZED WHEAT PROTEIN [] POLYSILICONE-11 [] RUBY POWDER [] SAPPHIRE POWDER [] NEPHRITE POWDER [] ETHYLHEXYLGLYCERIN [] PEARL POWDER [] LAURETH-7 [] METHICONE [] SORBITAN STEARATE [] CHOLESTEROL [] HYDROGENATED LECITHIN [] SIMMONDSIA CHINENSIS (JOJOBA) SEED OIL [] TRIETHYL CITRATE [] LINOLEIC ACID [] DISTEARDIMONIUM HECTORITE [] ETHYLHEXYL PALMITATE [] POLYMETHYLSILSESQUIOXANE [] PROPYLENE CARBONATE [] SODIUM HYALURONATE [] GOLD [] AMETHYST [] BORON NITRIDE [] TRIETHOXYCAPRYLYLSILANE [] ALUMINA [] SORBITAN ISOSTEARATE [] PALMITOYL OLIGOPEPTIDE [] PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE [] CETYL PEG/PPG-10/1 DIMETHICONE [] XANTHAN GUM [] ASCORBYL PALMITATE [] TOCOPHERYL ACETATE [] CHLOROXYLENOL [] PHENOXYETHANOL [] [+/- TITANIUM DIOXIDE (CI 77891) [] IRON OXIDES (CI 77491, CI 77492, CI 77499) [] MICA
WARNING: KEEP OUT OF EYES. STOP USE IF IRRITATION OCCURS.
KEEP OUT OF REACH OF CHILDREN.
PRINCIPAL DISPLAY PANEL
ESTEE LAUDER
RE-NUTRIV
ULTIMATE RADIANCE MAKEUP
SPF 15
1 FL OZ LIQUID/30 ML
ESTEE LAUDER DISTR.
NY, NY 10022
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 11559-746-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b0f5-f424-e053-dadaa90a57ce | 3bd1deb4-fbcb-497e-b3a4-a4e0a8864514 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11559-746-01 | RENUTRIVULTIMATE RADIANCE MAKEUP SPF 15 | 1 in 1 CARTON | LIQUID | 1 | 1 | |
| 11559-746-02 | RENUTRIVULTIMATE RADIANCE MAKEUP SPF 15 | 30 mL in 1 BOTTLE | LIQUID | 30 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| TITANIUM DIOXIDE | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 11559-746 | 11559-746-02, 11559-746-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| OCTINOXATE | 4Y5P7MUD51 | ACTIB |
| TITANIUM DIOXIDE | 15FIX9V2JP | ACTIB |
| WATER | 059QF0KO0R | IACT |
| BUTYLENE GLYCOL | 3XUS85K0RA | IACT |
| DIMETHICONE | 92RU3N3Y1O | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| BUTYLENE GLYCOL | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 8a53c88e-f816-48da-b647-13b847afe0fe | 3bd1deb4-fbcb-497e-b3a4-a4e0a8864514 | 2010-12-02 | Warnings | 8a53c88e-f816-48da-b647-13b847afe0fe 3bd1deb4-fbcb-497e-b3a4-a4e0a8864514 |
Adverse event summaries are temporarily unavailable. Other product information remains available.